Ensuring a cool recovery from cardiac arrest by Takeda, Yoshimasa
 
OU-MRU   Vol.2 Oct 2014 
Okayama University Medical Research Updates （OU-MRU） 
 
Source: Okayama University (JAPAN), Center for Public Information For immediate 
release:  29 October 2014 
 
Okayama University research: Ensuring a cool recovery from cardiac arrest 
 
(Okayama, 29 October 2014) Researchers at Okayama University in collaboration 
with several medical centres in Japan have demonstrated the safety and efficacy of 
a hypothermal treatment – pharyngeal cooling – for cardiac arrest patients. 
 
Cooling the brain is known to prevent neurological problems in patients recovering 
from cardiac arrest. However the most of current methods for therapeutic 
hypothermia may not be initiated before return of spontaneous circulation. 
 
Researchers at Okayama University investigated a method for cooling the area at the 
top of the throat – the pharynx - because the arteries that supply the head with 
oxygenated blood run nearby. Cooling this area should be a good approach to 
cooling the brain but so far there have been no complete studies to determine 
whether pharyngeal cooling could be administered effectively or whether it may lead 
to other adverse side effects. 
 
The researchers alongside people working in emergency and critical care clinics set 
up a trial for 108 cardiac arrest patients. The medical staff administered treatments 
with or without pharyngeal cooling to patients at random, and subsequently 
recorded success rates of resuscitation and  physiological conditions, including 
temperature both at the body core and in the head near the ear (tympanic 
temperature), mechanical or temperature damage to the pharynx, inflammation and 
blood platelet levels. 
 
The results of the trial indicated effective cooling of tympanic temperatures, with no 
observed adverse side effects. In addition, incidences of inflammation and blood-
clotting disorders were reduced in patients receiving pharyngeal cooling. As the 
researchers report, “In conclusion, it appears that the initiation of pharyngeal 
cooling is safe and feasible before and shortly after recovery of spontaneous 
circulation in the emergency room.” 
 
Background 
 
Hypothermia treatments and limitations 
 
Previous clinical data has indicated that quickly achieving therapeutic hypothermia is 
one of the most important factors for improving neurological outcomes for cardiac 
arrest patients. Approaches to achieving therapeutic hypothermia include 
intravenous infusion of cold fluid, which can increase re-arrest rates, and nasal 
cooling which is prone to cause extreme nosebleeds (epistaxis) and accumulation of 
air in soft tissues (peri-orbital emphysema). 
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Pharyngeal cooling method 
 
Pharyngeal cooling was begun during chest compression as soon as patients entered 
the emergency room or on return of spontaneous circulation (ROSC) if ROSC 
returned before entering the emergency room.  
 
In the current study pharyngeal cooling was administered using a pharyngeal cuff, a 
vinyl chloride tubular structure fitted into the upper oesophagus and pharynx. Saline 
solution at a temperature of 5 °C was perfused into the cuff at a rate of 500 ml 
min−1 and pressure of 50 cm H2O.  
 
The temperature was chosen to be above freezing so that ice did not form, and 
treatment duration was also limited to 2 hours to avoid damage from the cold. The 
pressure was chosen to be below 60 cm H2O to avoid neuropathy – nerve damage – 
which has been reported with the use of equipment similar to the cuff. 
 
Low mechanical damage to the pharynx was thought to be largely due to similarities 
between the cuff and other medical instruments, as clinicians administering the 
treatment were familiar with using similar equipment. 
 
Choice of patients 
 
Patients aged 14-89 years old were considered eligible for the study within 15 
minutes of collapse if they had suffered cardiogenic cardiac arrest or had been 
resuscitated from non-cardiogenic arrest by medical personnel.  A shortage of 
human resources meant that not all eligible patients were used in the study. Of the 
818 patients that met the criteria, 113 were enrolled on the study. The researchers 
believe that the relatively small size of the fraction of eligible patients that were 
enrolled does not affect the quality of the study data because the random selection 
for treatment with or without pharyngeal cooling was undertaken after enrolment, 
and exclusion from the study after enrolment was very low.  
 
Inflammation and blood clotting disorders post cardiac arrest 
 
Systemic Inflammatory Response Syndrome (SIRS) has been highlighted as an 
important factor linked to illnesses following cardiac arrest that include brain and 
heart injury and restricted blood supplies to tissue. Poor blood clotting 
(coagulopathy) is observed with whole body cooling and severe brain damage and 
low levels of platelets (thrombocytopaenia) can impair blood clotting.  
 
Incidences of all three diseases were diminished in patients treated with pharyngeal 
cooling: SIRS incidences in the pharyngeal cooling group amounted to 31% of 
patients compared with 57% in the control, coagulopathy incidences were lower in 
the first three days and thrombocytopaenia incidences dropped to zero compared 
with 17% of the control group 
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Figure 1 
 
 
Pharyngeal cooling cuff (left) and circulator (right). Physiological saline (5 °C) is 
initially supplied to the oesophageal cuff through the inflow tube, where the 
temperature is continuously monitored, and subsequently fills the pharyngeal cuff 
before being discharged through bilateral outlets. The bilateral outlets are 
connected to an outflow tube, where pressure is continuously monitored. According 
to a pilot study, intra-cuff pressures at the oesophageal and pharyngeal cuffs were 8 
cm H2O and 6 cm H2O higher than the pressure monitored at the outlet tube, 
respectively. The intra-cuff pressure at the pharyngeal cuff was controlled at 50 cm 
H2O. The cuff is made from vinyl chloride, has passed biological safety tests, and 
tolerates up to 200 cm H2O of intra-cuff pressure 
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About Okayama University 
Okayama University is one of the largest 
comprehensive universities in Japan with 
roots going back to the Medical Training  
Place sponsored by the Lord of Okayama  
and established in 1870. Now with 1,300 
faculty and 14,000 students, the University 
offers courses in specialties ranging from 
medicine and pharmacy to humanities  
a n d  p h y s i c a l  s c i e n c e s .  O k a y a m a  
University is located in the heart of Japan 
approximately 3 hours west of Tokyo by  
Shinkansen. 
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